Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
60.00
-3.04 (-4.82%)
Feb 26, 2026, 4:00 PM EST - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $8.64 billion as of February 27, 2026. Its market cap has decreased by -18.61% in one year.
Market Cap
8.64B
Enterprise Value
7.19B
1-Year Change
-18.61%
Ranking
Category
Stock Price
$60.00
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $8.64B, an increase of 525.76%. That is a compound annual growth rate of 37.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 8.64B | 42.97% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 9.98B |
| ImmunityBio | 9.81B |
| ABIVAX Société Anonyme | 9.74B |
| Praxis Precision Medicines | 9.68B |
| Bio-Techne | 9.05B |
| Arrowhead Pharmaceuticals | 8.63B |
| Axsome Therapeutics | 8.40B |
| Halozyme Therapeutics | 8.30B |